Differential mode of antimicrobial actions of arginine-rich and lysine-rich histones against Gram-positive Staphylococcus aureus.
We previously reported the activities and modes of action of arginine (Arg)-rich histones H3 and H4 against Gram-negative bacteria. In the present study, we investigated the properties of the Arg-rich histones against Gram-positive bacteria in comparison with those of lysine (Lys)-rich histone H2B. In a standard microdilution assay, calf thymus histones H2B, H3, and H4 showed growth inhibitory activity against Staphylococcus aureus with minimum effective concentration values of 4.0, 4.0, and 5.6 μM, respectively. Laser confocal microscopic analyses revealed that both the Arg-rich and Lys-rich histones associated with the surface of S. aureus. However, while the morphology of S. aureus treated with histone H2B appeared intact, those treated with the histones H3 and H4 closely resembled each other, and the cells were blurred. Electrophoretic mobility shift assay results revealed these histones have binding affinity to lipoteichoic acid (LTA), one of major cell surface components of Gram-positive bacteria. Scanning electron microscopic analyses demonstrated that while histone H2B elicited no obvious changes in cell morphology, histones H3 and H4 disrupted the cell membrane structure with bleb formation in a manner similar to general antimicrobial peptides. Consequently, our results suggest that bacterial cell surface LTA initially attracts both the Arg- and Lys-rich histones, but the modes of antimicrobial action of these histones are different; the former involves cell membrane disruption and the latter involves the cell integrity disruption.
Department of Biology, Faculty of Science, Toho University, 2-2-1 Miyama, Funabashi, Chiba 274-8510, Japan.
Shuu
S
Morita
Chihiro
C
Tagai
Takayuki
T
Shiraishi
Kazuyuki
K
Miyaji
Shawichi
S
Iwamuro
D000818:Animals; D000890:Anti-Infective Agents / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology*; D001120:Arginine / Q000737:chemistry; D002417:Cattle; D002462:Cell Membrane / Q000378:metabolism / Q000648:ultrastructure; D006657:Histones / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology*; D006801:Humans; D007700:Kinetics; D008070:Lipopolysaccharides / Q000378:metabolism; D008239:Lysine / Q000737:chemistry; D064347:Microscopy, Electrochemical, Scanning; D011485:Protein Binding; D013203:Staphylococcal Infections / Q000188:drug therapy / Q000473:pathology; D013211:Staphylococcus aureus / Q000187:drug effects / Q000648:ultrastructure; D013682:Teichoic Acids / Q000378:metabolism
D000890:Anti-Infective Agents; D006657:Histones; D008070:Lipopolysaccharides; D013682:Teichoic Acids; C009900:lipoteichoic acid; D001120:Arginine; D008239:Lysine
Antimicrobial peptides; Gram-positive bacteria; Histone H2B; Histone H3; Histone H4; Lipoteichoic acid